Guggenheim Insider Sentiment ETF (NFO) and Sabrient’s Index

Insider trading is Insider Monkey’s specialty. Academic studies have shown that stocks intensively purchased by insiders outperform index funds by more than 7% per year. Insider transactions are followed by several people and receive disproportional media coverage. However, there are not many funds that utilize insider transactions. Guggenheim is one of the few funds that capitalize on insider purchase data. Guggenheim has had an insider trading ETF (NFO) since late 2006 and this ETF has outperformed the broader market ETFs like SPY, IWM, and QQQQ.

We’re not in the business of promoting our competitors, but we are in the business of providing unbiased opinions about investing. The Guggenheim Insider Sentiment ETF (NFO) is not a pure play on insider trading. It’s based on Sabrient’s Insider Sentiment Index. Sabrient developed a quantitative methodology that picks stocks based on insider buying trends and increases in Wall Street analysts’ earnings estimates (Zacks.com provides a ranking service based on revisions in analysts’ earnings estimates). Here is how Sabrient’s Insider Sentiment Index is constructed:

  1. Potential Index constituents include all equities trading on major U.S. exchanges.
  2. The Insider Sentiment Index is comprised of the 100 highest-ranking securities chosen from a subset of companies covered by more than one analyst.
  3. Each company is ranked using a 100% quantitative rules-based methodology that includes composite scoring of a handful of specially-targeted factors, and is sorted from highest to lowest.
  4. The 100 highest-ranking securities are chosen and given an equal weighting in the portfolio.
  5. The constituent selection process and portfolio rebalance is repeated once per quarter.

Insider Monkey, your source for free insider trading data, doesn’t know much about earnings revisions. But we do know that stocks purchased by insiders perform spectacularly during the first month after the purchase. Sabrient’s methodology rebalances its portfolio quarterly, which means they’re 1.5 months late on the average. Guggenheim’s insider sentiment ETF doesn’t take advantage of the short term gains after the insider purchases. We don’t know what their exact methodology is but this must be reducing their overall performance by 2-4 percentage points per year. Considering they’re an $80 Million fund, they leave $1.6-$3.2 million on the table every year. (They should consider contacting us about a pure insider trading ETF).

Despite this deficiency in their methodology, they’ve managed to beat the market since inception. We wonder whether they truly have alpha or if it’s because they potentially have a value tilt in their portfolio. Insiders are usually contrarian investors (i.e. value investors) and value investing historically outperforms market indices. We used Carhart’s four factor model to calculate Guggenheim Insider Sentiment ETF’s alpha (See how to calculate alpha and beta).

Since its inception in September 2006, NFO managed to beat the market by 50 basis points per month. This is wonderful for the fund’s investors but one should not confuse this with alpha. NFO has a monthly alpha of 22 basis points. This is slightly more than 2.5 percentage points per year. The fund has a small cap tilt with a regression coefficient of 0.53. Small cap stocks performed well during the past 4 years and NFO benefited from this. Unfortunately this doesn’t count towards alpha. Surprisingly, NFO does not have a value tilt. Since insiders generally invest in value stocks, NFO’s methodology successfully screened out these stocks. This must be due to their use of increases in analysts’ earnings’ estimates as a criteria.

hedge funds vs. mutual funds

Overall this $80 Million ETF has a higher alpha than DFA’s Small Cap Value Fund (DFSVX) and Lakonishok’s LSVEX. It also has a larger alpha than do Warren Buffett (see our Warren Buffett articles) and most other fund managers endorsed by him. Insider Monkey hasn’t shared its proprietary methodology with its readers yet, but we can tell you that our historical returns are better than these publicly traded funds.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!